A programmed surface on polyetheretherketone for sequentially dictating osteoimmunomodulation and bone regeneration to achieve ameliorative osseointegration under osteoporotic conditions
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Polyetheretherketone (PEEK) is a desirable alternative to conventional biomedical metals for orthopedic implants due to the excellent mechanical properties. However, the inherent bioinertness of PEEK contributes to inferior osseointegration of PEEK implants, especially under pathological conditions of osteoporosis. Herein, a programmed surface is designed and fabricated on PEEK to dictate osteoimmunomodulation and bone regeneration sequentially. A degradable hybrid coating consisting of poly(lactide-co-glycolide) and alendronate (ALN) loaded nano-hydroxyapatite is deposited on PEEK and then interleukin-4 (IL-4) is grafted onto the outer surface of the hybrid coating with the aid of N2 plasma immersion ion implantation and subsequent immersion in IL-4 solution. Dominant release of IL-4 together with ALN and Ca2+ during the first few days synergistically mitigates the early acute inflammatory reactions and creates an osteoimmunomodulatory microenvironment that facilitates bone regeneration. Afterwards, slow and sustained delivery of ALN and Ca2+ in the following weeks boosts osteogenesis and suppresses osteoclastogenesis simultaneously, consequently ameliorating bone-implant osseointegration even under osteoporotic conditions. By taking into account the different phases in bone repair, this strategy of constructing advanced bone implants with sequential functions provides customizable and clinically viable therapy to osteoporotic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 2×
“According to our design: (1) Poly(lactideco-glycolide) (PLGA), a biodegradable and biocompatible polymer approved by FDA [22,23], is utilized as the coating material; (2) Alendronate (ALN), an effective therapeutic agent for preventing excessive bone resorption [24], is bound onto the osteo-inductive nano-hydroxyapati…”
An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering
Gentile, P., Chiono, V., Carmagnola, I., & Hatton, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033640 · Cited by 1,593
Implications of macrophage polarization in autoimmunity
Funes, S. C., Rios, M., Escobar‐Vera, J., & Kalergis, A. M. (2018) · Immunology · doi:10.1111/imm.12910 · Cited by 1,005 · cited 1×
“Among the various immune cells, macrophages play a crucial role in the host immune response, which mediates subsequent bone healing and ultimately determines the fate of implants in vivo [14, 30].”
BackgroundBacakova, L., Filova, E., Parizek, M., Ruml, T., & Svorcik, V. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.06.004 · Cited by 1,000
Brown, B. N., Ratner, B. D., Goodman, S. B., Amar, S., & Badylak, S. F. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.034 · Cited by 926
Spiller, K. L., Nassiri, S., Witherel, C. E., Anfang, R. R., Ng, J., Nakazawa, K. R., Yu, T., & Vunjak-Novakovic, G. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.017 · Cited by 773 · cited 1×
“370 release dominates in the first several days [26,32,33].”
BackgroundMa, Q.-L., Zhao, L.-Z., Liu, R.-R., Jin, B.-Q., Song, W., Wang, Y., Zhang, Y.-S., Chen, L.-H., & Zhang, Y.-M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.025 · Cited by 319
PDGF in bone formation and regeneration: New insights into a novel mechanism involving MSCs
Caplan, A. I., & Correa, D. (2011) · Journal of Orthopaedic Research · doi:10.1002/jor.21462 · Cited by 312
Bai, L., Du, Z., Du, J., Yao, W., Zhang, J., Weng, Z., Liu, S., Zhao, Y., Liu, Y., Zhang, X., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.010 · Cited by 265 · cited 1×
“In response to the physicochemical properties of the implant surface, immune cells are recruited to the implant surface to alter the local microenvironment by switching phenotypes [14,15].”
BackgroundFan, L., Guan, P., Xiao, C., Wen, H., Wang, Q., Liu, C., Luo, Y., Ma, L., Tan, G., Yu, P., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.005 · Cited by 152 · cited 1×
“Bone mesenchymal stem cells are the precursor cells of osteoblasts and their proliferation is fundamental to bone regeneration in vivo [45].”
Background
Cited by
Li, X., Si, Y., Liang, J., Li, M., Wang, Z., Qin, Y., & Sun, L. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.05.209 · Cited by 72
Bisphosphonate-incorporated coatings for orthopedic implants functionalization
Zhang, J., Bai, H., Bai, M., Wang, X., Li, Z., Xue, H., Wang, J., Cui, Y., Wang, H., Wang, Y., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100737 · Cited by 22
“[230] developed a degradable hybrid coating consisting of ALN-loaded nano-HA deposited on PEEK.”
BackgroundSelf-citationZhang, Y., Yang, S., Hao, J., Zhang, Y., Chen, Y., & Jia, Z. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c03079 · Cited by 7
Metadata
- Authors
- Zheng, Y., Gao, A., Bai, J., Liao, Q., Wu, Y., Zhang, W., Guan, M., Tong, L., Geng, D., Zhao, X., Chu, P. K., & Wang, H.
- Venue
- Bioactive Materials
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 14
- Pages
- 364-376
- ISSN
- 2097-1192 (ISSN-L)
- 2452-199X
- OpenAlex
- W4210700294
- Cited by
- 110
- References
- 10
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.